Argent BioPharma (RGT) Stock Chart & Stock Price History GBX 5.68 -0.82 (-12.62%) (As of 12/20/2024 12:06 PM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitors Argent BioPharma Stock Price Performance 5 Day Performance-6.75%1 Month Performance-63.71%3 Month Performance-67.11% Receive RGT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Argent BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. RGT Stock Chart for Sunday, December, 22, 2024 RGT Chart by TradingView Argent BioPharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 5.61GBX 5.68+1.23%GBX 5.68GBX 5.611,197 shs£3.05 million12/19/2024GBX 5.50GBX 5.61+2.02%GBX 8GBX 56,872 shs£3.01 million12/18/2024GBX 6.90GBX 5.50-20.29%GBX 7.97GBX 5.1127,003 shs£2.95 million12/17/2024GBX 6.09GBX 6.90+13.28%GBX 7GBX 5.1137,563 shs£3.70 million12/16/2024GBX 7GBX 6.09-12.99%GBX 6.95GBX 6.0928,907 shs£3.27 million12/13/2024GBX 6GBX 7+16.67%GBX 7.94GBX 6.0333,944 shs£3.75 million Get the Latest News and Ratings for RGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Argent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 7.90GBX 6-24.05%GBX 6.10GBX 68,371 shs£3.22 million12/11/2024GBX 6.15GBX 7.90+28.46%GBX 8.17GBX 6.219,025 shs£4.24 million12/10/2024GBX 8GBX 6.15-23.13%GBX 9GBX 6.0331,742 shs£3.30 million12/09/2024GBX 8.50GBX 8-5.88%GBX 9.40GBX 736,543 shs£4.29 million12/06/2024GBX 7.36GBX 8.50+15.49%GBX 9.40GBX 7.1610,773 shs£4.56 million12/05/2024GBX 7.12GBX 7.36+3.37%GBX 9.45GBX 745,234 shs£3.95 million12/04/2024GBX 9GBX 7.12-20.89%GBX 9.95GBX 7.1241,877 shs£3.82 million12/03/2024GBX 9.15GBX 9-1.64%GBX 10.73GBX 923,647 shs£4.83 million12/02/2024GBX 10.50GBX 9.15-12.86%GBX 11.48GBX 937,547 shs£4.91 million11/29/2024GBX 15.03GBX 10.50-30.14%GBX 11.35GBX 6113,522 shs£5.63 million11/28/2024GBX 15.10GBX 15.03-0.46%GBX 15.50GBX 15.0377 shs£8.06 million11/27/2024GBX 15GBX 15.10+0.67%GBX 16.90GBX 15210 shs£8.10 million11/26/2024GBX 15GBX 15GBX 17GBX 15758 shs£8.04 million11/25/2024GBX 16GBX 15-6.25%GBX 16.90GBX 1528,007 shs£8.04 million11/22/2024GBX 15.65GBX 16+2.24%GBX 16.90GBX 15.6510,709 shs£8.58 million11/21/2024GBX 15.65GBX 15.65GBX 16.60GBX 15.5510,791 shs£8.39 million11/20/2024GBX 15.25GBX 15.65+2.62%GBX 16.75GBX 15.5561,673 shs£8.39 million Related Companies N4 Pharma Stock Price Chart Hellenic Dynamics Stock Price Chart Haleon Stock Price Chart Hikma Pharmaceuticals Stock Price Chart HUTCHMED Stock Price Chart Indivior Stock Price Chart Allergy Therapeutics Stock Price Chart Alliance Pharma Stock Price Chart Beximco Pharmaceuticals Stock Price Chart Animalcare Group Stock Price Chart Receive RGT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Argent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (LON:RGT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Argent BioPharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Argent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.